Sort by
Refine Your Search
-
Category
-
Country
-
Employer
- Leiden University
- CNRS
- ETH Zürich
- Maastricht University (UM)
- Munster Technological University
- Utrecht University
- VIB
- Friedrich Schiller University Jena •
- Institute of Public Health University of Porto
- Ludwig-Maximilians-Universität München •
- Nantes Université
- National Institute of Research and Innovation
- Purdue University
- REQUIMTE - Rede de Quimica e Tecnologia
- SciLifeLab
- Technical University of Denmark (DTU)
- Technological University Dublin
- UCLouvain
- UNIVERSITY OF HELSINKI
- Ulm University •
- Universitat de Barcelona
- University of Göttingen •
- University of Salerno
- University of Twente (UT)
- 14 more »
- « less
-
Field
-
Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description The PhD candidate will be recruited within IJCLab (http://ijclab.in2p3.fr
-
-derived pollutants (microplastics, pesticides, pharmaceuticals) into the very heart of these ecodiverse hotspots, making them vulnerable to far-field human interference. While this general knowledge is now
-
)’. Unfortunately, this connection brings land-derived pollutants (microplastics, pesticides, pharmaceuticals) into the very heart of these ecodiverse hotspots, making them vulnerable to far-field human interference
-
heterocyclic compounds of significant pharmaceutical interest. Where to apply Website https://emploi.cnrs.fr/Offres/Doctorant/UPR8241-ERIMAN-004/Default.aspx Requirements Research FieldChemistryEducation
-
and will be supervised by: Main supervisor: Dr. Rik Mom, Leiden University https://www.universiteitleiden.nl/en/research/research-projects/science/operando-research-in-electrochemistry Co-supervisor: Dr
-
safety assessments that better reflect human diversity. What you bring MSc in (Bio)-pharmaceutical Sciences, Biomedical Sciences or Biology Expertise in (human) induced pluripotent stem cell culture, 3D in
-
PhD project which is a collaboration between the Karolinska Institute, SciLifeLab and Ribocure Pharmaceuticals AB. The PhD student will be employed by Ribocure Pharmaceuticals AB but admitted to PhD
-
with high potential in pharmaceutical sciences Characterization, drug design development, and biological evaluation of protein-protein interaction inhibitors Application and valorization potential in
-
resources and the increasing presence of emerging pollutants (pharmaceutical residues, pesticides, endocrine disruptors, per- and polyfluoroalkyl compounds – PFAS) pose major challenges for modern societies
-
priorities in Industry 5.0, smart manufacturing, digitalisation, and sustainability. The outcomes are expected to be of significant interest to manufacturing, pharmaceutical, food processing, and automation